Tecentriq: Data from P3 IMpassion031 trial (NCT03197935) for neoadjuvant TNBC in 2020 (Roche) - Sep 17, 2019 - Pharma Day: Data from P3 IMvigor010 trial (NCT02450331) as adjuvant therapy in patients with high-risk muscle-invasive bladder cancer in 2020
P3 data
|